Blogs

In Celebration of Eric Ott
by Bob Riter
August 17, 2015

Related News

Bevacizumab Active in HIV-Linked Kaposi's Sarcoma

Mar 20, 2012

Phase 2 study shows overall response rate of 31 percent in patients with poor-prognosis HIV-KS


Ridaforolimus Promising for Treating Advanced Sarcomas

Nov 9, 2011

Clinical benefit seen for patients with advanced sarcomas of different histopathologic subtypes


Racial Disparity Seen in Ewing Sarcoma Patients

Aug 29, 2015

Disease is nine times more common among Caucasians than African Americans